- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06365294
Rescue Extracranial Vertebral Stenting in Tandem Occlusions (REVET)
April 10, 2024 updated by: Dr. Cuong Tran Chi
The acute vertebrobasilar occlusion associated with the poor prognosis, particularly tandem occlusion.
However, few data on the efficacy of the endovascular therapy was indicated in this occlusion.
We reported whether the additional rescue extracranial stenting improved clinical outcome by modified Rankin Scale (mRS) score within 3 months after the procedure
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Acute vertebrobasilar artery occlusion is one of the cerebrovascular diseases with high disability and mortality rates.
Although mechanical thrombectomy has recently been demonstrated an effective treatment for large vessel occlusions of posterior circulation, the treatment strategies depending on the specific pathophysiology.
Tandem occlusion in posterior circulation is less frequently than in anterior one, comprises severe stenosis or occlusion of the extracranial vertebral artery ipsilateral to its intracranial and basilar occlusion.
The recent studies showed the benefit of the "distal-to-proximal" approach, there were many tecniques to achieved the successful recanalization.
Besides, the use of Dotter technique allowed 8F guiding catheter to cross the extracranial lesions easily and save the procedural time.
However, the Diagnosis 5F-Dotter, like the Dilator-Dotter, has not been mentioned in previous studies.
Therefore, the aim of the our study was to assess the improvement of outcomes at 3 months posttreatment in patients receiving rescue extracranial vertebral stenting
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Cuong Tran Chi, PhD
- Phone Number: +84886559911
- Email: drcuongtran@dotquy.vn
Study Contact Backup
- Name: Can Tho Stroke International Services Hospital
- Phone Number: +84886559911
Study Locations
-
-
-
Cần Thơ, Vietnam, 900000
- Recruiting
- Can Tho SIS Hospital
-
Contact:
- Cuong Tran Chi, Doctor
- Phone Number: +84886559911
- Email: drcuongtran@dotquy.vn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age > 18 years old
- Onset to treatment time < 24 hours
- NIHSS > 5
- pc-ASPECTS ≥ 5
Exclusion Criteria:
- Premorbid mRS > 2
- Extensive, bilateral brain-stem infarction on neuroimaging
- Cerebellar mass effect on neuroimaging
- Loss to follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rescue extracranial vertebral stenting
Rescue extracranial vertebral stenting in tandem occlusions
|
Rescue extracranial stenting in tandem occlusions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The good 3-month outcome rate
Time Frame: 3 months
|
The good 3-month outcome rate was accessed by modified Rankin Score (mRS ≤ 2).
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Can Tho Stroke International Services Hospital, Can Tho Stroke International Services General Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cohen JE, Leker RR, Gomori JM, Eichel R, Rajz G, Moscovici S, Itshayek E. Emergent revascularization of acute tandem vertebrobasilar occlusions: Endovascular approaches and technical considerations-Confirming the role of vertebral artery ostium stenosis as a cause of vertebrobasilar stroke. J Clin Neurosci. 2016 Dec;34:70-76. doi: 10.1016/j.jocn.2016.05.005. Epub 2016 Aug 10.
- Han N, Ma L, Zhao L, Xu G, Jia Y, Wang H. The Dilator-Dotter technique can successfully treat tandem lesions of posterior circulation. Medicine (Baltimore). 2024 Jan 26;103(4):e37044. doi: 10.1097/MD.0000000000037044.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 31, 2020
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
October 31, 2024
Study Registration Dates
First Submitted
April 10, 2024
First Submitted That Met QC Criteria
April 10, 2024
First Posted (Estimated)
April 15, 2024
Study Record Updates
Last Update Posted (Estimated)
April 15, 2024
Last Update Submitted That Met QC Criteria
April 10, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REVET Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Stroke
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Cidat, S.A. de C.V.El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezUnknownStroke | Stroke, Acute | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, AcuteMexico
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingStroke, Acute ThromboticCanada
-
University of MiamiTemporarily not availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Dongzhimen Hospital, BeijingThe Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaboratorsRecruitingStroke, Ischemic | Stroke, Acute | Acute Ischemic StrokeChina
-
University Hospital, MontpellierNot yet recruiting
-
Capital Medical UniversityRecruitingAcute Stroke | Ischemic Stroke, AcuteChina
-
Chonbuk National University HospitalKorean Society of Neurosonology; Ministry of SMEs and Startups, Republic of... and other collaboratorsCompleted
-
National Taiwan University HospitalCompleted
-
University of EdinburghNHS LothianRecruiting
Clinical Trials on Rescue extracrnial stenting
-
Can Tho Stroke International Services HospitalCompletedThrombosis | Stent Stenosis | Ischemic Stroke, AcuteVietnam
-
Assiut UniversityNot yet recruitingIschemic Stroke | Thromboembolic Stroke
-
Can Tho Stroke International Services HospitalCompletedIschemic Stroke | Intracranial Hemorrhages | Stroke, Ischemic | Stent Stenosis | Acute Stroke | Cerebral Ischemia | Intracranial Atherosclerosis | Stent Occlusion | Thrombotic Stroke, AcuteVietnam
-
Acandis GmbHRecruiting
-
Yonsei UniversityCompletedAcute Ischemic Stroke | Intracranial Artery OcclusionKorea, Republic of
-
Marco ValgimigliUnknownMyocardial InfarctionItaly
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Medical University of SilesiaSilesian University of MedicineUnknown
-
Lallemand Pharma AGCompleted
-
University of Alabama at BirminghamNot yet recruiting